| Literature DB >> 35747638 |
Nata Parnes1,2, Alexis B Sandler3, John C Dunn3, Olivia Duvall1, John P Scanaliato3.
Abstract
Purpose: To report mid-term outcomes of active-duty patients younger than the age of 35 years with shoulder type II SLAP lesions following our technique for double-pulley SLAP repair (DPSR).Entities:
Year: 2022 PMID: 35747638 PMCID: PMC9210478 DOI: 10.1016/j.asmr.2022.04.009
Source DB: PubMed Journal: Arthrosc Sports Med Rehabil ISSN: 2666-061X
Fig 1Right shoulder, type II SLAP tear with a normal biceps tendon as viewed from the standard posterolateral viewing portal.
Fig 2Right shoulder, glenoid neck debrided to bleeding bone with a 4.5-mm shaver as viewed from the standard posterolateral viewing portal.
Fig 3Right shoulder, first 1.9-mm double-loaded SUTUREFIX (Smith & Nephew, Andover MA) is placed at the 10-o’clock position as viewed from the anterior–superior portal.
Fig 4Right shoulder, first knot tied and the remaining suture limbs are passed through the labrum as viewed from the anterior-superior portal (arrow indicates suture limbs).
Fig 5Right shoulder, all 4 limbs are retrieved through the transrotator cuff portal as viewed from the standard posterolateral viewing portal. Note that a 1.7-mm double-loaded SUTUREFIX (Smith & Nephew, Andover MA) anchor has been placed in line with the anterior edge of the biceps tendon (arrow).
Fig 6Right shoulder (on screen), one limb from each portal is coupled into a double-pulley configuration as viewed from the standard posterolateral viewing portal.
Fig 7Right shoulder, final knot tying and completion of repair as viewed from the standard posterolateral viewing portal.
Fig 8Right shoulder, adequacy of repair is assessed with an arthroscopic probe as viewed from the standard posterolateral viewing portal.
Fig 9Flowchart of patient inclusion.
Study Population Characteristics
| Patients (shoulders) | 22 (22) |
|---|---|
| Follow-up, mo (range) | 85.27 (72-95) |
| Age, y (range) | 27.73 (19-34) |
| % Male | 100% |
| % Right shoulder | 54.5% |
| % Dominant shoulder | 54.5% |
| % Combat arms | 68.2% |
| Concomitant procedures | |
| Arthroscopic subacromial decompression | 22/22 (100%) |
| Arthroscopic distal clavicle resection | 2/22 (9.1%) |
| Anterior labral repair | 6/22 (27.3%) |
| Posterior labral repair | 8/22 (36.4%) |
| Glenoid microfracture | 4/22 (18.2%) |
| Debridement of partial articular-sided supraspinatus tear | 4/22 (18.2%) |
Non-administrative/non-support infantry, artillery, and/or military police.
Outcome Measures
| Outcome Measure | Preoperative, Mean (SD) | Postoperative, Mean (SD) | Difference, | 95% CI | |
|---|---|---|---|---|---|
| ASES | 40.05 (14.4) | 86.18 (11.8) | 46.14 (16.2) | 39.37-52.90 | <.0001 |
| SANE | 38.18 (18.6) | 81.82 (15.6) | 43.64 (17.7) | 36.25-51.02 | <.0001 |
| Pain VAS | 8.05 (1.6) | 1.34 (1.4) | –6.70 (1.6) | –7.39 to –6.02 | <.0001 |
| Forward flexion | 156.82 (4.8) | 156.59 (5.0) | –0.23 (2.9) | –1.43 to 0.98 | .8778 |
| External rotation | 67.73 (4.3) | 66.14 (6.5) | –1.59 (4.7) | –3.57 to 0.38 | .1294 |
| Internal rotation | T9.82 (1.8) | T10.09 (1.8) | T0.27 (2.0) | –0.56 to 1.11 | .1918 |
ASES, American Shoulder and Elbow Surgeons; CI, confidence interval; SANE, Single Assessment Numeric Evaluation; SD, standard deviation; VAS, visual analog scale.
The difference is the mean postoperative score minus the mean preoperative score; positive values indicate greater postoperative values, on average.
The 95% CI represents the CI for the difference between the mean postoperative score minus the mean preoperative score.
Percentage of Patients Meeting the MCID, SCB, and PASS Thresholds
| MCID | SCB | PASS | |
|---|---|---|---|
| ASES | 100% | 90.9% | 95.45% |
| SANE | 100% | 100% | 86.35% |
| Pain VAS | 100% | 100% | 94.45% |
NOTE. Values: ASES: MCID 11, SCB 16.8, PASS 59.6; SANE: MCID 3.5, SCB 5.8, PASS 65.5; Pain VAS: MCID -1.29, SCB -2.51, PASS 2.74.
ASES, American Shoulder and Elbow Surgeons; MCID, Minimum clinically important difference; PASS, patient acceptable symptomatic state, SANE, Single Assessment Numeric Evaluation; SCB, substantial clinical benefit; VAS, visual analog scale.